Question · asked by 1 review

Transarterial embolisation and transarterial chemoembolisation vs no intervention: Death during study period

It is very uncertain whether transarterial embolisation and transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Transarterial embolisation and transarterial chemoembolisation vs no intervention
Mortality at 44 months from trial entry Number of participants · people with liver metastases
It is very uncertain whether transarterial embolisation and transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).
Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases (2020) · Cochrane Headline outcomes only
RR 0.88 [0.74, 1.06]1 study · 61 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
2020 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.